Filing Details
- Accession Number:
- 0001179110-19-005874
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-10 16:10:16
- Reporting Period:
- 2019-05-08
- Accepted Time:
- 2019-05-10 16:10:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1017832 | P Martin Sutter | 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2019-05-08 | 12,000 | $7.67 | 192,550 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2019-05-08 | 801 | $257.88 | 191,749 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2019-05-08 | 1,100 | $259.06 | 190,649 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2019-05-08 | 1,297 | $260.10 | 189,352 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2019-05-08 | 566 | $261.04 | 188,786 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2019-05-08 | 900 | $262.08 | 187,886 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-05-08 | 12,000 | $0.00 | 12,000 | $7.67 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-08-11 | 2019-08-12 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $9.99 | 2011-08-10 | 2020-08-11 | 12,000 | 12,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2020-08-11 | 12,000 | 12,000 | Direct |
Footnotes
- Grant to reporting person of option to buy shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- Exercise of stock options in advance of the expiration of ten year contractual term of the underlying awards.
- Sale of common stock solely for the payment of tax liability associated with the exercise of options.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $257.5700 and $258.5500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $258.7000 and $259.5400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $259.5800 and $260.5000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $260.6100 and $261.5500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $261.6200 and $262.4500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
